Carriel-Mancilla Jorge, Suárez Rosario, Frias-Toral Evelyn, Bautista-Valarezo Estefanía, Andrade Zambrano Trino, Andrade García Andrés, Muñoz Jaramillo Roberto, Ferrín Mario, Martin Jimmy, Cardoso Ramos Almino, Carella Angelo Michele, Verde Ludovica, Muscogiuri Giovanna, Sarno Gerardo
Weight Loss Journey, Hospital de Especialidades Clínica Dr. Trino Andrade, Sambonondón, Ecuador.
Escuela de Graduados, Universidad Católica Santiago de Guayaquil, Guayaquil, Ecuador.
Minerva Endocrinol (Torino). 2024 Dec 6. doi: 10.23736/S2724-6507.24.04193-9.
Bariatric surgery (BS) stands as a highly effective intervention for severe obesity; however, limited understanding exists regarding its short to medium-term complications. This study aimed to analyze short-medium term complications in patients undergoing BS in an Ecuadorian hospital.
A retrospective cohort study included 1132 patients who underwent BS between October 2021 and April 2022, specifically evaluating those with complications needing hospital readmission. Demographic, clinical, surgical, and therapeutic data were collected. The degree of complications was evaluated using the Clavien-Dindo classification.
Out of the 1132 patients, 1.6% experienced early complications requiring hospital readmission within the first six months post-BS. Complications occurred in 7% of patients with revisional surgery, 2% with gastric bypass, and 1.2% with gastric sleeve. The most common complications were stenosis (28%), leaks/fistulas (17%), gallbladder and/or bile duct pathologies (17%), and fever (17%). Management strategies involved conservative treatment (28%), combined endoscopic and surgical approaches (28%), and surgical reintervention alone (33%). According to the Clavien-Dindo classification, 28% presented mild-moderate and 72% serious complications.
BS showed a low incidence of early complications that required readmission. However, a substantial proportion (almost 70%) of patients with early complications experienced severe ones, resulting in prolonged hospital stays. These findings emphasize the need for ongoing monitoring and specialized care in the postoperative period, contributing valuable insights to the safety profile of BS in an Ecuadorian context.
减肥手术是治疗重度肥胖的一种高效干预措施；然而，人们对其短期至中期并发症的了解有限。本研究旨在分析厄瓜多尔一家医院接受减肥手术患者的短期和中期并发症。
一项回顾性队列研究纳入了2021年10月至2022年4月期间接受减肥手术的1132例患者，特别评估了那些因并发症需要再次入院治疗的患者。收集了人口统计学、临床、手术和治疗数据。采用Clavien-Dindo分类法评估并发症的严重程度。
在1132例患者中，1.6%出现早期并发症，需要在减肥手术后的前六个月内再次入院。翻修手术患者中7%出现并发症，胃旁路手术患者中2%出现并发症，胃袖状切除术患者中1.2%出现并发症。最常见的并发症是狭窄（28%）、渗漏/瘘管（17%）、胆囊和/或胆管病变（17%）以及发热（17%）。处理策略包括保守治疗（28%）、内镜和手术联合治疗（28%）以及单纯手术再次干预（33%）。根据Clavien-Dindo分类法，28%为轻至中度并发症，72%为严重并发症。
减肥手术显示需要再次入院的早期并发症发生率较低。然而，相当一部分（近70%）有早期并发症的患者出现了严重并发症，导致住院时间延长。这些发现强调了术后持续监测和专科护理的必要性，为厄瓜多尔背景下减肥手术的安全性提供了有价值的见解。
